MMP-2 and Fibronectin Fragmentation in Periodontal Diseases and Oral Cancer
牙周病和口腔癌中的 MMP-2 和纤连蛋白断裂
基本信息
- 批准号:7223440
- 负责人:
- 金额:$ 33.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAdverse effectsAmino Acid SequenceApoptosisArthritisBindingBinding SitesBiochemicalBiologicalC-terminalCell Adhesion MoleculesCell physiologyCleaved cellCollagenConditionDataDevelopmentDigestionDisciplineDiseaseDisease ProgressionEnzymesExposure toFamilyFibronectinsGelatinase AGoalsGrowth FactorHemopexinHomeostasisIndividualInflammatoryInstitutionInterceptLengthLigand Binding DomainMaintenanceMalignant NeoplasmsMapsMass Spectrum AnalysisMatrix MetalloproteinasesMetalsMethodsMolecularMolecular BiologyMutationNeoplasm MetastasisNormal tissue morphologyPeptidesPeriodontal DiseasesPhage DisplayPositioning AttributeProtein EngineeringProteinsProteolysisRandom Peptide LibrariesRecombinantsResearch PersonnelScreening procedureSeriesSiteSite-Directed MutagenesisTestingTissuesbasecancer cellcell behaviordesigninhibitor/antagonistmalignant mouth neoplasmnovel strategiesresearch studyresponsesynthetic peptidetumor
项目摘要
DESCRIPTION (provided by applicant): The enzymes in the family of matrix metalloproteinases (MMPs) are important to regular tissue maintenance by their collective capacity to degrade major tissue molecules and activating growth factors. The MMPs contribute hereby beneficially to normal development and tissue adaptation. Nevertheless, certain MMPs, including MMP-2, have been found at elevated levels and may abnormally degrade tissues in several diseases, such as periodontal disease, arthritis, and cancer. Recent studies by ourselves and other investigators have shown that the major cell adhesion molecule fibronectin is degraded in those diseases and that MMP-2 can efficiently cleave fibronectin. This degradation requires specific binding between fibronectin and a unique subdomain of MMP-2. Since the behavior of cells changes upon exposure to the fibronectin cleavage fragments, such fragments may alter the disease progression. Therefore, understanding the precise mechanism of binding between the two proteins may provide the basis for developing inhibitors that can block MMP-2 degradation of fibronectin. In a collaborative effort that involves investigators from different disciplines and institutions, we will apply molecular biology, biochemical, mass spectrometry, and protein engineering methods to define the precise binding sites for fibronectin and MMP-2. Based on results gained from screening of phage-displayed random peptide libraries, we will design synthetic peptides, which mimic the binding sites, and test their capacity to block both MMP-2 binding and degradation of fibronectin. Introduction of site-specific mutations in binding domains will confirm the binding sites. After precisely mapping the fibronectin cleavage sites and fragments, we will characterize altered periodontal and cancer cell behavior by multiple parameters, MMP expression, and apoptosis in response to contact with a series of recombinant fibronectin cleavage fragments. We will then test the capacity of the inhibitory peptides to rescue cell functions. This experimental strategy should define the specific binding sites for the interactions between MMP-2 and fibronectin and pursues a novel strategy to inhibit degradation of specific molecules by individual MMPs, such as cleavage of fibronectin by MMP-2. Successful inhibition of fibronectin fragmentation could be of significant benefit for the management of both periodontal disease and oral cancer.
描述(由申请人提供):基质金属蛋白酶(MMP)家族中的酶通过其降解主要组织分子和激活生长因子的集体能力对定期组织维护很重要。MMP由此有益地促进正常发育和组织适应。然而,某些MMP,包括MMP-2,已被发现在升高的水平,并可能异常降解组织在几种疾病,如牙周病,关节炎和癌症。近年来,我们和其他研究者的研究表明,在这些疾病中,主要的细胞粘附分子纤连蛋白被降解,MMP-2可以有效地切割纤连蛋白。这种降解需要纤连蛋白和MMP-2的独特亚结构域之间的特异性结合。由于细胞的行为在暴露于纤连蛋白切割片段时发生变化,因此此类片段可改变疾病进展。因此,了解这两种蛋白质之间结合的确切机制可能为开发能够阻断MMP-2降解纤连蛋白的抑制剂提供基础。在涉及来自不同学科和机构的研究人员的合作努力中,我们将应用分子生物学,生物化学,质谱和蛋白质工程方法来定义纤连蛋白和MMP-2的精确结合位点。基于噬菌体展示随机肽库筛选的结果,我们将设计模拟结合位点的合成肽,并测试其阻断MMP-2结合和纤连蛋白降解的能力。在结合结构域中引入位点特异性突变将确认结合位点。在精确绘制纤连蛋白切割位点和片段后,我们将通过多个参数、MMP表达和细胞凋亡来表征与一系列重组纤连蛋白切割片段接触后牙周和癌细胞行为的改变。然后,我们将测试抑制肽拯救细胞功能的能力。这种实验策略应该定义MMP-2和纤连蛋白之间相互作用的特异性结合位点,并寻求一种新的策略来抑制单个MMP降解特定分子,例如MMP-2切割纤连蛋白。成功地抑制纤维连接蛋白断裂可能对牙周病和口腔癌的治疗都有显著的益处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BJORN STEFFENSEN其他文献
BJORN STEFFENSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BJORN STEFFENSEN', 18)}}的其他基金
MMP-2 and Fibronectin Fragmentation in Periodontal Diseases and Oral Cancer
牙周病和口腔癌中的 MMP-2 和纤连蛋白断裂
- 批准号:
7425425 - 财政年份:2006
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 and Fibronectin Fragmentation in Periodontal Diseases and Oral Cancer
牙周病和口腔癌中的 MMP-2 和纤连蛋白断裂
- 批准号:
7617708 - 财政年份:2006
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 and Fibronectin Fragmentation in Periodontal Diseases and Oral Cancer
牙周病和口腔癌中的 MMP-2 和纤连蛋白断裂
- 批准号:
7014708 - 财政年份:2006
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 and Fibronectin Fragmentation in Periodontal Diseases and Oral Cancer
牙周病和口腔癌中的 MMP-2 和纤连蛋白片段
- 批准号:
7843595 - 财政年份:2006
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 in Periodontal Disease and Oral Cancer
MMP-2 在牙周病和口腔癌中的作用
- 批准号:
7485776 - 财政年份:2004
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 in Periodontal Disease and Oral Cancer
MMP-2 在牙周病和口腔癌中的作用
- 批准号:
6851316 - 财政年份:2004
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 in Periodontal Disease and Oral Cancer
MMP-2 在牙周病和口腔癌中的作用
- 批准号:
7115208 - 财政年份:2004
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 in Periodontal Disease and Oral Cancer
MMP-2 在牙周病和口腔癌中的作用
- 批准号:
6954201 - 财政年份:2004
- 资助金额:
$ 33.67万 - 项目类别:
MMP-2 in Periodontal Disease and Oral Cancer
MMP-2 在牙周病和口腔癌中的作用
- 批准号:
7276742 - 财政年份:2004
- 资助金额:
$ 33.67万 - 项目类别:
Craniofacial Oral-biology Student Training in Academic Research (COSTAR)
颅面口腔生物学学生学术研究培训(COSTAR)
- 批准号:
7867917 - 财政年份:2002
- 资助金额:
$ 33.67万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 33.67万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 33.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 33.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 33.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 33.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 33.67万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 33.67万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 33.67万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 33.67万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 33.67万 - 项目类别:
Discovery Grants Program - Individual